Hosted on MSN1mon
22nd Century Group Stock Rises On Proposed FDA Mandate On Nicotine Content: Retail's Extremely Bullish
Shares of 22nd Century Group Inc. ($XXII), a tobacco products-focused company, rose nearly 22% on Monday as a U.S. Food and Drug Administration proposal to mandate ...
BBC1y
The 22nd Century people living among us
In the third of three films about "deep time", journalist and author Richard Fisher reflects on the 22nd Century citizen in ... crucial insights into early Chinese civilisation.
CNN1y
22nd Century Group, Inc.
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science.
ETF Daily News24d
22nd Century Group’s (XXII) “Sell (E+)” Rating Reiterated at Weiss Ratings
Shares of NASDAQ:XXII opened at $5.10 on Friday. 22nd Century Group has a 1 year low of $3.90 and a 1 year high of $581.85. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 ...
Nasdaq1mon
22nd Century Group Supports FDA's Proposed Reduced Nicotine Content Standard Following OMB Review Completion
22nd Century Group, Inc. announced its support for the FDA's proposed standard to reduce nicotine content in cigarettes, which recently cleared review by the Office of Management and Budget.